 beta-Galactosidase
"beta-Galactosidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.
| Descriptor ID |
D001616
|
| MeSH Number(s) |
D08.811.277.450.410.100
|
| Concept/Terms |
beta-Galactosidase- beta-Galactosidase
- beta Galactosidase
- beta-Galactosidases
- beta Galactosidases
- lac Z Protein
- Protein, lac Z
- Lactases
- beta-D-Galactosidase
- beta D Galactosidase
Lactrase- Lactrase
- Rivex Brand of beta-Galactosidase
- Rivex Brand of beta Galactosidase
Dairyaid- Dairyaid
- Tanta Brand of beta-Galactosidase
- Tanta Brand of beta Galactosidase
Lactaid- Lactaid
- Sunrise Brand of beta-Galactosidase
- Sunrise Brand of beta Galactosidase
- McNeil Brand of beta-Galactosidase
Lactogest- Lactogest
- Thompson Brand of beta-Galactosidase
- Thompson Brand of beta Galactosidase
|
Below are MeSH descriptors whose meaning is more general than "beta-Galactosidase".
Below are MeSH descriptors whose meaning is more specific than "beta-Galactosidase".
This graph shows the total number of publications written about "beta-Galactosidase" by people in this website by year, and whether "beta-Galactosidase" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "beta-Galactosidase" by people in Profiles.
-
Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Pharmacogenet Genomics. 2008 Jan; 18(1):25-35.
-
Castro P, Giri D, Lamb D, Ittmann M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate. 2003 Apr 01; 55(1):30-8.
-
Myer A, Wagner DS, Vivian JL, Olson EN, Klein WH. Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo. Dev Biol. 1997 May 15; 185(2):127-38.
-
Kasof GM, Mandelzys A, Maika SD, Hammer RE, Curran T, Morgan JI. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J Neurosci. 1995 Jun; 15(6):4238-49.
-
Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI, Curran T. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron. 1995 Feb; 14(2):241-52.
-
Chen SC, Curran T, Morgan JI. Apoptosis in the nervous system: new revelations. J Clin Pathol. 1995 Jan; 48(1):7-12.
-
Molinar-Rode R, Smeyne RJ, Curran T, Morgan JI. Regulation of proto-oncogene expression in adult and developing lungs. Mol Cell Biol. 1993 Jun; 13(6):3213-20.
-
Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 1993 May 13; 363(6425):166-9.
-
Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, Morgan JI. fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron. 1992 Jan; 8(1):13-23.
-
Schilling K, Luk D, Morgan JI, Curran T. Regulation of a fos-lacZ fusion gene: a paradigm for quantitative analysis of stimulus-transcription coupling. Proc Natl Acad Sci U S A. 1991 Jul 01; 88(13):5665-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|